Clinical trial
Assessment of Opuntia Ficus-indica Supplementation on Improving Antioxidant and Inflammation Levels
NCT06657963 is registered in ClinicalTrials.gov with LifeTree Asia Sdn Bhd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Opuntia Ficus-indica Supplementation on Improving Antioxidant and Inflammation Levels
- Lead sponsor
- LifeTree Asia Sdn Bhd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2023
- Completion date
- December 31, 2023
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antioxidant capabilities, inflammation biomarkers